{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:54:01Z","timestamp":1791546841405,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","award":["St. Baldrick\\u2019s Foundation Infrastructure Grant"],"award-info":[{"award-number":["St. Baldrick\\u2019s Foundation Infrastructure Grant"]}],"id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008630","name":"Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.08.047","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:23:10Z","timestamp":1787959390000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Belumosudil Demonstrates Steroid-Sparing, Safety, and Efficacy in Pediatric Chronic Graft-Versus-Host Disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6985-0941","authenticated-orcid":false,"given":"Amitesh","family":"Anerao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4462-5213","authenticated-orcid":false,"given":"Joan","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-2502","authenticated-orcid":false,"given":"Geoffrey","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Djassemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3990-2193","authenticated-orcid":false,"given":"Jane","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5168-9271","authenticated-orcid":false,"given":"Danielle","family":"Mucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Lenon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chana","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Nakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-3473","authenticated-orcid":false,"given":"David","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-9082","authenticated-orcid":false,"given":"Geetha","family":"Puthenveetil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2781-5627","authenticated-orcid":false,"given":"Van","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Nikam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-1415","authenticated-orcid":false,"given":"Maria","family":"Buethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5849-0960","authenticated-orcid":false,"given":"Rishikesh","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.08.047_bib0001","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.2024026633","article-title":"FDA-approved therapies for chronic GVHD","volume":"145","author":"Lee","year":"2025","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.047_bib0002","doi-asserted-by":"crossref","first-page":"712.e1","DOI":"10.1016\/j.jtct.2022.07.014","article-title":"Association of chronic graft-versus-host disease with late effects following allogeneic hematopoietic cell transplantation for children with hematologic malignancy","volume":"28","author":"Lee","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.08.047_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101054","article-title":"Chronic graft-versus-host disease in pediatric patients: differences and challenges","volume":"60","author":"Haroun","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2026.08.047_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.808103","article-title":"Management of chronic graft-vs.-host disease in children and adolescents with ALL: present status and model for a personalised management plan","volume":"10","author":"Sobkowiak-Sobierajska","year":"2022","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.047_bib0005","doi-asserted-by":"crossref","first-page":"907.e1","DOI":"10.1016\/j.jtct.2024.06.023","article-title":"Real-world outcomes of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in Japan: retrospective analysis of the transplant registry unified management program registry","volume":"30","author":"Kanda","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.047_bib0006","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood.2019000216","article-title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","volume":"134","author":"Cuvelier","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.047_bib0007","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/bloodadvances.2025017393","article-title":"Impact of age on graft-versus-host disease and overall survival in pediatric hematopoietic cell transplant recipients","volume":"10","author":"Nishitani","year":"2026","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.08.047_bib0008","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41409-020-0899-0","article-title":"Financial impact of post-transplant complications among children undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Ricci","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.047_bib0009","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ejh.14281","article-title":"Graft-versus-host disease in patients with bone marrow transplants: a retrospective study analyzing outcomes and healthcare burden in US hospitals","volume":"113","author":"Patel","year":"2024","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.047_bib0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41409-023-01930-8","article-title":"Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France","volume":"58","author":"Michonneau","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.047_bib0011","doi-asserted-by":"crossref","first-page":"224.e1","DOI":"10.1016\/j.jtct.2024.12.019","article-title":"Pediatric transplant and cellular therapy consortium RESILIENT conference on pediatric chronic graft-versus-host disease survivorship after hematopoietic cell transplantation: Part IV. Patient important outcomes","volume":"31","author":"Rotz","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.08.047_bib0012","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and co-stimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.047_bib0013","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bjh.14295","article-title":"Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation","volume":"175","author":"Zeiser","year":"2016","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.08.047_bib0014","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/ijms17081288","article-title":"Role of toll-like receptor signaling in the pathogenesis of graft-versus-host diseases","volume":"17","author":"Tu","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.047_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.047_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2214\/AJR.17.17866","article-title":"Imaging of abdominal and pelvic manifestations of graft-versus-host disease after hematopoietic stem cell transplant","volume":"209","author":"Lubner","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.047_bib0017","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.2021012431","article-title":"Nonclassical manifestations of acute GVHD","volume":"138","author":"Zeiser","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.047_bib0018","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jtct.2026.08.047_bib0019","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68-69","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jtct.2026.08.047_bib0020","article-title":"TGF-\u03b2 inhibitors: the future for prevention and treatment of liver fibrosis?","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2026.08.047_bib0021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/1744666X.2017.1279053","article-title":"Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment","volume":"13","author":"Gr\u00f8nnings\u00e6ter","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.047_bib0022","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease \u2013 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.047_bib0023","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtct.2026.08.047_bib0024","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1182\/bloodadvances.2024014374","article-title":"Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis","volume":"9","author":"Pidala","year":"2025","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.047_bib0025","doi-asserted-by":"crossref","first-page":"771.e1","DOI":"10.1016\/j.jtct.2022.08.021","article-title":"Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1\/2 iMAGINE study","volume":"28","author":"Carpenter","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"17","key":"10.1016\/j.jtct.2026.08.047_bib0026","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/bloodadvances.2019000631","article-title":"Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children","volume":"3","author":"Whangbo","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2026.08.047_bib0027","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00277-024-06128-6","article-title":"Belumosudil in pediatric patients with chronic graft-versus-host disease after failed multi-line therapy: a case series","volume":"104","author":"Chen","year":"2025","journal-title":"Ann Hematol"},{"issue":"47","key":"10.1016\/j.jtct.2026.08.047_bib0028","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.jtct.2026.08.047_bib0029","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study [published correction appears in Blood. 2022 Mar 17;139(11):1772]","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.08.047_bib0030","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-21-4176","article-title":"FDA Approval Summary: belumosudil for adult and pediatric patients 12 years and older with chronic GvHD after two or more prior lines of systemic therapy","volume":"28","author":"Przepiorka","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.jtct.2026.08.047_bib0031","doi-asserted-by":"crossref","first-page":"434.e1","DOI":"10.1016\/j.jtct.2025.04.020","article-title":"Belumosudil for chronic graft-versus-host disease: analysis of long-term results from the KD025-208 and ROCKstar studies","volume":"31","author":"Lee","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.08.047_bib0032","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","article-title":"Axatilimab in recurrent or refractory chronic graft-versus-host disease (AGAVE-201)","volume":"391","author":"Wolff","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.08.047_bib0033","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.08.047_bib0034","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.047_bib0035","doi-asserted-by":"crossref","first-page":"707.e1","DOI":"10.1016\/j.jtct.2022.04.014","article-title":"Healthcare resource utilization and costs of steroid-associated complications in patients with graft-versus-host disease","volume":"28","author":"Bell","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"18","key":"10.1016\/j.jtct.2026.08.047_bib0036","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/cells13181524","article-title":"Current approaches for the prevention and treatment of acute and chronic GVHD","volume":"13","author":"Olivieri","year":"2024","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.jtct.2026.08.047_bib0037","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1182\/bloodadvances.2022008095","article-title":"Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials","volume":"6","author":"DeFilipp","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2026.08.047_bib0038","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/s41409-021-01389-5","article-title":"Steroid-refractory chronic graft-versus-host disease: treatment options and patient management","volume":"56","author":"Wolff","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.08.047_bib0039","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/ajh.27040","article-title":"Updates in chronic graft-versus-host disease management","volume":"98","author":"Malard","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.08.047_bib0040","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1016\/j.bbmt.2011.12.448","article-title":"Systemic effects of oral budesonide in hematopoietic transplant: implications of drug interaction with azoles","volume":"18","author":"Obi","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.08.047_bib0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbmt.2008.12.406","article-title":"High budesonide bioavailability in patients with gastro-intestinal (GI) graft versus host disease (GVHD) AND\/OR clostridium difficile infection","volume":"15","author":"Frame","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726006895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:26:42Z","timestamp":1791545202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726006895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S2666636726006895"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.047","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belumosudil Demonstrates Steroid-Sparing, Safety, and Efficacy in Pediatric Chronic Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}